Your browser doesn't support javascript.
loading
Breast-conserving therapy is safe both within BRCA1/2 mutation carriers and noncarriers with breast cancer in the Chinese population.
Huang, Xin; Cai, Xiu-Yu; Liu, Jia-Qi; Hao, Wen-Wen; Zhou, Yi-Dong; Wang, Xiang; Xu, Ying; Chen, Chang; Lin, Yan; Wang, Chang-Jun; Song, Yu; Sun, Qiang.
Afiliação
  • Huang X; Departments of Breast Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China.
  • Cai XY; Department of VIP Region, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Liu JQ; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Hao WW; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhou YD; Departments of Breast Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China.
  • Wang X; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Xu Y; Departments of Breast Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China.
  • Chen C; Departments of Breast Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China.
  • Lin Y; Departments of Breast Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China.
  • Wang CJ; Departments of Breast Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China.
  • Song Y; Departments of Breast Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China.
  • Sun Q; Departments of Breast Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China.
Gland Surg ; 9(3): 775-787, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32775268
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Gland Surg Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Gland Surg Ano de publicação: 2020 Tipo de documento: Article